Search Content
Jenkins, Ann
SDCF - News and updates
In this area you will find all the latest news and updates relating to our plans for a Safer Drug Consumption Facility (SDCF).
Item No 06 - Internal Audit Update - 1 Dec 2023 - 30 April 2024
To present to the Glasgow City Integration Joint Board Finance, Audit and Scrutiny Committee details of the Internal Audit work undertaken at Glasgow City Council and NHS Greater Glasgow and Clyde that may have an impact upon the Glasgow City Integration Joint Board.
Item No 08 - Outturn Report 2023-24
To provide a high-level overview of the Integration Joint Board’s draft outturn position for 2023/24, and to seek approval for the transfer of funds to reserves to allow completion of the Integration Joint Board’s accounts by the statutory deadline of 30 September 2024.
Item No 07 - Chief Internal Auditors Annual Report 2023-24
To present to the IJB Finance, Audit and Scrutiny Committee the Chief Internal Auditor’s Annual Report for 2023/24.
Item No 03 - IJB Finance Audit and Scrutiny Committee (M) 17-04-2024 - DRAFT
Item No 05 - Rolling Action List
Agenda - 12/06/2024
Item No 14 - Adult Support and Protection - 2023 Annual Joint Self-Evaluation
To advise the IJB Finance, Audit and Scrutiny Committee of the Adult Support and Protection (ASP) 2023 joint audit and related improvement work to support the delivery of the Glasgow City Health and Social Care Partnership (GCHSCP) ASP policies and procedures.
To request that the findings are noted along with the method and model used for self-evaluation, the related improvement actions and agree to an updated report being submitted to IJB Finance, Audit and Scrutiny Committee detailing the audit findings for 2024.
Item No 16 - Risk Management Q4 Update
The purpose of this report is to provide an update to the IJB Finance, Audit and Scrutiny Committee on the status of the IJB’s risk register and to highlight key operational risks being managed in the Glasgow City Health and Social Care Partnership.
This report covers the review carried out in respect of changes to risk in Quarter 4 (1 January 2024 to 31 March 2024).